Build vs Buy: The True Cost of Health Data Infrastructure

Every product team building a health-aware app eventually hits the same fork in the road: do we build the health data layer ourselves, or integrate something that already exists?

The question sounds simple. The answer rarely is.

This article lays out what “building it yourself” actually entails — not the optimistic estimate from a planning meeting, but the full engineering, operational, and opportunity cost picture. It also covers when building in-house genuinely is the right call, because sometimes it is.

What “health data infrastructure” actually means

Before comparing build vs buy, it helps to define the scope. A health data layer that’s ready for production typically includes:

1. Device integration — connecting to Apple HealthKit, Google Health Connect, and potentially direct wearable SDKs (Garmin, Fitbit, Oura, etc.)
2. Data collection — background syncing that works reliably across OS versions, battery optimization modes, and permission states
3. Normalization — converting heterogeneous data formats, units, sampling rates, and naming conventions into a consistent schema
4. Deduplication — resolving overlapping data when a user has multiple sources (phone accelerometer + watch + third-party app)
5. Biomarker computation — deriving meaningful health metrics (sleep efficiency, HRV averages, activity intensity breakdowns) from raw samples
6. Scoring and analysis — turning metrics into actionable signals your product can consume (health scores, trends, comparisons)
7. Delivery — APIs and/or webhooks that serve processed data to your backend, CDP, or client app
8. Compliance — handling health data under HIPAA, GDPR, and other regulatory frameworks with appropriate encryption, consent management, and audit trails

Most teams who say “we’ll just pull from HealthKit” are thinking about step 1. Production requires all eight.

The real cost of building in-house

Engineering time: the initial build

A reasonable estimate for a team building a production-quality health data pipeline from scratch:

At a fully loaded cost of $150K–$200K per senior engineer per year (salary, benefits, equity, tooling) [1], that’s roughly $400K–$1M before you ship a single health-aware feature to users.

And that estimate assumes your team already has domain expertise in health data. If they’re learning as they go — parsing Apple’s HealthKit documentation, understanding what “time in bed” vs “asleep” vs “core sleep” actually means across different devices — add 30–50% to every line item.

Maintenance: the cost that never stops

The initial build is the part teams plan for. Maintenance is the part that surprises them.

OS and API updates. Apple and Google update their health data APIs at least once a year with their major OS releases. These updates regularly introduce breaking changes, deprecate data types, or alter permission flows. Each update cycle requires 2–6 weeks of engineering time to test, adapt, and re-certify.

Device fragmentation. There are hundreds of Android device models with different sensor configurations, sampling rates, and Health Connect implementations. A pipeline that works on a Pixel may silently produce incorrect data on a Samsung or Xiaomi [2][3]. Ongoing QA across devices is a permanent line item.

Data quality monitoring. Health data is noisy. Sensors drift, users switch devices, wearables lose Bluetooth connections mid-sleep. A production system needs monitoring for data gaps, anomalies, and quality regressions — and someone needs to respond when alerts fire.

Compliance evolution. Privacy regulations change. New state-level health data laws, updated HIPAA guidance, evolving GDPR enforcement precedents — each requires review and potentially architectural changes.

A conservative estimate for ongoing maintenance: 1–2 full-time engineers permanently allocated, or $150K–$400K per year, indefinitely.

The hidden cost: opportunity

Engineering time is a zero-sum resource. Every sprint your team spends debugging a HealthKit background sync issue on iOS 19 is a sprint not spent on your core product — the features that differentiate you, the experience users pay for.

This is the cost that doesn’t show up in a budget spreadsheet but often matters most. For most companies, health data plumbing is not the product. It’s the prerequisite for the product.

When building in-house makes sense

Buy isn’t always the right answer. Building your own health data layer is defensible when:

Health data processing is your core differentiator. If your company’s entire value proposition depends on a proprietary way of processing health data — a novel algorithm, a unique clinical model, a patented scoring methodology — then owning the full pipeline protects your moat.

You have specialized clinical or regulatory requirements. Some digital therapeutics or clinical research applications need FDA-compliant data provenance, specific sampling protocols, or integration with medical-grade devices that consumer APIs don’t cover.

You already have the team. If you have a dedicated health data engineering team with deep domain expertise and the work is already done or well underway, the switching cost to a vendor may not justify the transition.

Your scale changes the economics. At very high user volumes (millions of daily active profiles), the per-unit economics of an API can exceed the cost of maintaining your own infrastructure — though this break-even point is higher than most teams assume.

For everyone else — which is most companies — the math favors buying.

The buy side: what a health data API handles

A purpose-built health data API typically collapses those eight infrastructure components into a single integration. Instead of building each layer, your team:

• Drops in an SDK (iOS, Android, or cross-platform)
• Configures which data types to collect
• Receives normalized, deduplicated, scored data via API or webhooks

The vendor handles device integration, background sync, normalization, deduplication, biomarker derivation, compliance, and ongoing maintenance. Your team consumes clean outputs.

Integration time for a well-documented health data API: days to weeks, not months.

Ongoing maintenance on your side: near zero for the health data layer itself. You maintain your business logic on top of it, which is where your effort belongs.

A framework for deciding

Rather than debating build vs buy in the abstract, run it through these five questions:

1. Is health data processing your core product?

If yes → lean build. If no → lean buy. Most companies are building a product that uses health data, not a product that is health data processing.

2. What’s your time to market?

If you need health features in production within 1–3 months, building isn’t realistic. If you have 12+ months and the team to support it, building is feasible (though still not necessarily optimal).

3. How many data sources do you need?

If you only need step counts from Apple Health — and you’re certain that won’t expand — a lightweight direct integration might be enough. If you need multiple data types across platforms with derived metrics, the complexity curve favors an API.

4. Do you have health data domain expertise on the team?

This is often the deciding factor. Health data has domain-specific complexity (sleep staging algorithms, HRV computation methods, activity classification thresholds) that takes years to build institutional knowledge around. If your team would be learning this from scratch, you’re paying a steep tuition cost.

5. What does your total cost of ownership look like over 3 years?

Run the numbers honestly:

The numbers vary by team and scale, but the gap is usually wider than teams expect going in.

The hybrid approach

Some teams take a middle path: use an API for the data collection, normalization, and biomarker layer, then build proprietary logic on top of the clean outputs. This captures most of the build-vs-buy advantage while preserving room for differentiation where it matters — in how your product interprets and acts on health data, not in how it collects and cleans it.

This is often the strongest position: own the intelligence layer, outsource the plumbing.

What to evaluate in a health data API

If you decide to buy, not all health data APIs are equivalent. Key evaluation criteria:

• Device and source coverage — how many platforms and data types are supported out of the box
• Data quality — normalization depth, deduplication accuracy, handling of edge cases
• Derived metrics — whether the API provides computed biomarkers, scores, and behavioral insights or just raw data pass-through
• Latency — real-time delivery vs batch processing, and whether webhooks are supported
• SDK quality — native support for your platform (iOS, Android, React Native, Flutter), background sync reliability, and developer experience
• Compliance — HIPAA, GDPR, SOC 2, and other certifications relevant to your market
• Documentation and support — the quality of docs, sample apps, and engineering support often predicts integration speed
• Pricing model — per-user, per-API-call, or tiered — and how it scales with your growth

Conclusion

The build-vs-buy decision for health data infrastructure comes down to a clear question: is building and maintaining health data plumbing the best use of your engineering team’s time and your company’s capital?

For teams where health data processing is the product, building makes sense. For teams where health data is an input to the product — which is the majority — buying collapses months of engineering into days, eliminates an entire class of ongoing maintenance, and frees the team to focus on what actually differentiates the product.

The most expensive health data infrastructure is the one that delays your product by six months while your competitors ship.